Inactive Instrument

Company Sun Biopharma Inc

Equities

Software

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Sun Biopharma Inc

Business Summary

Sun BioPharma, Inc., formerly Cimarron Medical, Inc., is a clinical stage drug development company. The Company is a biopharmaceutical company focused on developing therapies for pancreatic diseases. It is engaged in the commercial development of a polyamine analogue for pancreatic cancer and for a second indication in chronic pancreatitis. The Company's products include SBP-101, SBP-102 and SBP-103. Its SBP-101 is a polyamine compound and exhibits specificity for the exocrine pancreas, with therapeutic potential for both pancreatic cancer and pancreatitis indications. It develops SBP-101 for the treatment of patients with pancreatic ductal adenocarcinoma. The SBP-102 product is in non-clinical feasibility evaluation for the treatment of patients with pancreatitis. The SBP-103 product is in non-clinical exploratory evaluation. The Company has enrolled first patient in its Phase I clinical trial of SBP-101 in patients with previously treated pancreatic cancer.

Managers

Managers TitleAgeSince
Founder 78 11-09-20
Chief Executive Officer 55 20-07-15
Director of Finance/CFO 65 18-04-16
Chief Operating Officer - 12-03-31
Chief Tech/Sci/R&D Officer - 22-05-31
Corporate Officer/Principal - 21-05-31
- -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 55 20-07-15
Director/Board Member 63 15-09-29
Founder 78 11-09-20
Director/Board Member 62 22-06-14
Director/Board Member 58 19-12-15
Director/Board Member 59 22-06-14
Director/Board Member 68 15-09-03

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,854,882 4,854,791 ( 100.00 %) 21 ( 0.000432 %) 100.00 %

Shareholders

NameEquities%Valuation
Citadel Securities GP LLC
0.0352 %
1,711 0.0352 % 753 $
Goldman Sachs & Co. LLC
0.0253 %
1,226 0.0253 % 539 $
Tower Research Capital LLC
0.0155 %
751 0.0155 % 330 $
Two Sigma Securities LLC
0.0120 %
584 0.0120 % 257 $
Donald Schemel
0.000453 %
22 0.000453 % 10 $
Michael Cullen
0.000453 %
22 0.000453 % 10 $
Dan Donovan
0.000227 %
11 0.000227 % 5 $
Susan Horvath
0.000144 %
7 0.000144 % 3 $
7 0.000144 % 3 $
Woodbury Financial Services, Inc.
0.000082 %
4 0.000082 % 2 $

Company contact information

Panbela Therapeutics, Inc.

712 Vista Boulevard Suite 305

55387, Waconia

+952 479 1196

http://www.panbela.com
address Sun Biopharma Inc
  1. Stock Market
  2. Equities
  3. Stock
  4. Company Sun Biopharma Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW